A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer

NCT03829345 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Oesophageal Cancer
Gastro-Oesophageal Junction Cancer
Gastric Cancer

Interventions

DRUG: Olaparib

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

[object Object]